Drugs Made In America Acquisition (DMIIR) Current Assets (2024 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Current Assets of $26037.0 for Q4 2025, down 56.32% year-over-year from $59615.0 in Q4 2024, and down 97.1% quarter-over-quarter from $896356.0 in Q3 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Current Assets (2024 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Current Assets for 2 consecutive years, with $26037.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 56.32% year-over-year to $26037.0; the TTM figure through Dec 2025 stood at $26037.0 (down 56.32% YoY), while the FY2025 annual figure was $26037.0, down 56.32% from the prior year.
- Current Assets retreated to $26037.0 in Q4 2025 per DMIIR's latest filing, from $896356.0 in the prior quarter.
- Across five years, Current Assets topped out at $896356.0 in Q3 2025 and bottomed at $26037.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 92,716.00 |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | 223,206.00 |
| 4 | Armada Acquisition | 666.23 Mn | 666.18 Mn | - | 177,850.00 |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | 554,262.00 |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | 962,384.00 |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | 335,263.00 |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | 1.29 Mn |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | 460,082.00 |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | 217,823.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217,823.00 |
| Dec 31, 2025 | 26,037.00 |
| Sep 30, 2025 | 896,356.00 |
| Dec 31, 2024 | 59,615.00 |